Copper Levels in Patients with Unexplained Dysplastic Cytopenia

Area of Science:

• Hematology
• Clinical Biochemistry

Background:

• Copper deficiency can present with hematological changes that mimic myelodysplastic syndromes.
• The prevalence of copper deficiency in patients with unexplained cytopenias and dysplasia is not well-established.

Purpose of the Study:

• To evaluate the prevalence of copper deficiency in patients presenting with unexplained cytopenias and dysplasia.
• To determine the clinical utility of routine copper level testing in this patient cohort.

Main Methods:

• Prospective evaluation of 17 patients with unexplained cytopenias and/or dysplasia.
• Measurement of serum copper levels in recruited patients.

Main Results:

• Only one out of 17 patients (approximately 5.9%) exhibited low copper levels.
• This study represents the first investigation into hypocupremia in patients with isolated hematological manifestations.

Conclusions:

• Copper deficiency appears to be an uncommon cause of unexplained cytopenias and dysplasia in hematology patients.
• Routine copper level testing in this population is unlikely to be cost-effective.
• A risk-stratified approach to copper testing, considering patient history and clinical signs, is recommended.